← FDA Drug Approvals (Drugs@FDA)
FIRDAPSE
NDA · New Drug Application · Sponsor: CATALYST PHARMS · Approved 2018-11-28
Drug application
- FDA Application #
NDA208078
- Application type
- New Drug Application
- Brand name
- FIRDAPSE
- Generic name
- AMIFAMPRIDINE PHOSPHATE
- Active ingredients
- AMIFAMPRIDINE PHOSPHATE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- CATALYST PHARMS
- Manufacturer
- Catalyst Pharmaceuticals, Inc.
- First approval
- 2018-11-28
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown